The stereoselectivity of antitumor active [1,2-diamino-1-phenylpropane]dichloroplatinum(II) complexes

Inorganica Chimica Acta

Volumn 264, Issue 1-2, 1997, Pages 145-160

  Gust, Ronald ^a   Gelbcke, Michael ^b   Angermaier, Bernhard ^c   Bachmann, Helmut ^c   Krauser, Rudolf ^c   Schönenberger, Helmut ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Antitumor activity; Diamine complexes; Platinum complexes; Stereoselectivity

Indexed keywords

AMINES; CELL CULTURE; ENANTIOMERS; STEREOSELECTIVITY;

ANTI-TUMOR ACTIVITIES; COMPLEX CONFORMATION; DIAMINE COMPLEXES; DIASTEREOMERIC; MCF-7 BREAST CANCER CELLS; OPTICAL PURITY; PLATINUM COMPLEXES; PT COMPLEXES;

PLATINUM COMPOUNDS;

EID: 0000913094     PISSN: 00201693     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0020-1693(97)05603-x     Document Type: Article

References (48)

1. B. Rosenberg, L. Van Camp, J.E. Trosko and V.H. Mansour, Nature, 222 (1969) 385-386.
2. M.J. Cleare, P.C. Hydes, D.R. Hepburn and B.W. Malerbi, in A.W. Prestayko, S.T. Crooke and S.K. Carter (eds.), Cisplatin Current Status and New Developments, Academic Press, New York, 1980, pp. 149-170.
3. E. von Angerer, E. Holler, H. Schönenberger and R. Schönenberger, in D.F. Smith (ed.). Handbook of Stereoisomers: Therapeutic Drugs, CRC Press, Boca Raton, FL, 1989, pp. 247-284.
4. M. Gulotti, A. Pasini, R. Ugo, St. Filippeschi, L. Marmonti and F. Spreafico, Inorg. Chim. Acta, 91 (1984) 223-227.
5. H. Brunner, P. Hankofer, U. Holzinger, B. Treittinger and H. Schönenberger, Eur. J. Med. Chem., 25 (1990) 35-44.
6. B. Wappes, M. Jennerwein, E. von Angerer, J. Engel, H. Schönenberger, H. Brunner, M. Schmidt, M.R. Berger, D. Schmähl and S. Seeber, J. Cancer Res. Clin. Oncol., 107 (1984) 15-20.
7. M. Noji, Y. Gohchi and Y. Kidani, Chem. Biol. Interact., 51 (1984) 37-48.
8. H.-D. vom Orde, H. Reile, R. Müller, R. Gust, G. Bernhard, Th. Spruß, H. Schönenberger, Th. Burgemeister and A. Mannschreck, J. Cancer Res. Clin. Oncol., 116 (1990) 434-438.
9. M. Jennerwein, B. Wappes, R. Gust, H. Schönenberger, J. Engel, S. Seeber and R. Osieka, J. Cancer Res. Clin. Oncol., 114 (1988) 347-358.
10. R. Gust, H. Schönenberger, J. Kritzenberger, K.-J. Range, U. Klement and Th. Burgemeister, Inorg. Chem., 32 (1993) 5939-5950.
11. M. Jennerwein, R. Gust, R. Müller, H. Schönenberger, J. Engel, M.R. Berger, D. Schmähl, S. Seeber, R. Osieka, G. Atassi and D. Maréchal-De Bock, Arch. Pharm. (Weinheim), 322 (1989) 67-73.
12. S. Schertl, R. Gust, R. Müller, Th. Spruß and H. Schönenberger, Arch. Pharm. (Weinheim), 325 (1992) 113-118.
13. M. Noji, K. Okamoto, Y. Kidani and T. Tashiro, J. Med. Chem., 24 (1981) 508-515.
14. Y. Kidani, Yakugaku Zasshi, 105 (1985) 909-925.
15. Z.H. Siddik, S. Al-Baker, T.L. Burditt and A.R. Khokhar, J. Cancer Res. Clin. Oncol., 120 (1993) 12-16.
16. Z.H. Siddik, S. Al-Baker, G. Thai and A.R. Khokhar, J. Cancer Res. Clin. Oncol., 120 (1994) 409-414.
17. H. Bachmann, Ph.D. Thesis, University of Regensburg, Germany, 1996.
18. K. Niebler, Ph.D. Thesis, University of Regensburg, Germany, 1993.
19. D.T. Tytgat and M. Gelbcke, Bull. Soc. Chim. Belg., 99 (1990) 329-334.
20. R. Gust, R. Krauser, B. Schmid and H. Schonenberger, Inorg. Chim. Acta, 250 (1996) 203-218.
21. D. Tytgat and M. Gelbcke, Bull Soc. Chim. Belg., 10 (1992) 479-489.
22. D. Tytgat, M. Gelbcke and D.F. Smith, Pharmazie, (1990) 835-836.
23. D. Tytgat, Ph.D. Thesis, Free University of Brussel, Belgium, 1991.
24. R.W. Berg and K. Rasmussen, Spectrochim. Acta, Part A, 29 (1973) 319-327.
25. R. Gust, K. Niebler and H. Schönenberger, J. Med. Chem., 38 (1995) 2070-2079.
26. D.F. Smith, in D.F. Smith (ed.). Handbook of Stereoisomers, CRC Press. Boca Raton, FL, 1989, p. 4.
27. S.J. Lippard, Pure Appl. Chem., 59 (6) (1987) 731-742.
28. S.J. Lippard, Metals in medicine, in I. Bertini, H.B. Gray, S.J. Lippard and J.S. Valentine (eds.), Bioinorganic Chemistry, University Science Books, Mill Valley, CA, 1994, pp. 519-583.
29. A. Sigel and H. Sigel (eds.), Interactions of Metal Ions with Nucleotides, Nucleic Acids, and their Constituents, Metal Ions in Biological Systems, Vol. 32, Marcel Dekker, New York, 1996; M.J. Bloemink and J. Reedijk, Cisplatin and derived anticancer drugs: mechanism and current status of DNA binding, p. 641; J.P. Whitehead and S.J. Lippard, Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts, p. 687. J.-C. Chottard, J.-P. Girault, G. Chottard, J.-Y. Lallemand and D. Mansuy, J. Am. Chem. Soc., 102 (1980) 5565.
30. A. Sigel and H. Sigel (eds.), Interactions of Metal Ions with Nucleotides, Nucleic Acids, and their Constituents, Metal Ions in Biological Systems, Vol. 32, Marcel Dekker, New York, 1996; M.J. Bloemink and J. Reedijk, Cisplatin and derived anticancer drugs: mechanism and current status of DNA binding, p. 641; J.P. Whitehead and S.J. Lippard, Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts, p. 687. J.-C. Chottard, J.-P. Girault, G. Chottard, J.-Y. Lallemand and D. Mansuy, J. Am. Chem. Soc., 102 (1980) 5565.
31. A. Sigel and H. Sigel (eds.), Interactions of Metal Ions with Nucleotides, Nucleic Acids, and their Constituents, Metal Ions in Biological Systems, Vol. 32, Marcel Dekker, New York, 1996; M.J. Bloemink and J. Reedijk, Cisplatin and derived anticancer drugs: mechanism and current status of DNA binding, p. 641; J.P. Whitehead and S.J. Lippard, Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts, p. 687. J.-C. Chottard, J.-P. Girault, G. Chottard, J.-Y. Lallemand and D. Mansuy, J. Am. Chem. Soc., 102 (1980) 5565.
32. A. Sigel and H. Sigel (eds.), Interactions of Metal Ions with Nucleotides, Nucleic Acids, and their Constituents, Metal Ions in Biological Systems, Vol. 32, Marcel Dekker, New York, 1996; M.J. Bloemink and J. Reedijk, Cisplatin and derived anticancer drugs: mechanism and current status of DNA binding, p. 641; J.P. Whitehead and S.J. Lippard, Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts, p. 687. J.-C. Chottard, J.-P. Girault, G. Chottard, J.-Y. Lallemand and D. Mansuy, J. Am. Chem. Soc., 102 (1980) 5565.
33. J.-P. Girauld, G. Chottard, J.-Y. Lallemand and J.-C. Chottard, Biochemistry, 21 (1982) 1352.
34. J.H.J. den Hartog, C. Altona, J.-C. Chottard, J.-P. Girauld, J.-Y. Lallemand, F.A.A.M. de Leeuw, A.J.M. Marcelis and J. Reedijk, Nucleic Acids Res., 10 (1982) 4715.
35. S.E. Sherman, D. Gibson, A.H.-J. Wang and S.J. Lippard, Science, 250 (1985) 412.
36. P.M. Takahara, A.M. Rosenzweig, C.A. Frederick and S.J. Lippard, Nature, 377 (1995) 649-652.
37. J. A. Mello, S.J. Lippard and J.M. Essigmann, Biochemistry, 34 (1995) 14783-14791.
38. M. Gniazdowski and C. Cera, Chem. Rev., 96 (1996) 619-634.
39. J. Reedijk, Inorg. Chim. Acta, 198-200 (1992) 873-881.
40. M.J. Bloemink, R.J. Heetebrij, K. Inagaki, Y. Kidani and J. Reedijk, Inorg. Chem., 31 (1992) 4656-4661.
41. K. Vickery, A.M. Bonin, R.R. Fenton, S. O'Mara, P.J. Russel, L.K. Webster and T.W. Hambley, J. Med. Chem., 36 (1993) 3663-3668.
42. K. Inagaki and Y. Kidani, Inorg. Chem., 25 (1986) 1-3.
43. K. Inagaki, C. Ninomiya and Y. Kidani, Chem. Lett., (1986) 233-236.
44. M. Gullotti, G. Pacchioni, A. Pasini and R. Ugo, Inorg. Chem., 21 (1982) 2006-2014.
45. A. Pasini, A. Velcich and A. Mariani, Chem. Biol. Interact., 42 (1982) 311-320.
46. M. Koch, Ph.D. Thesis, University of Regensburg, Germany, 1993.
47. H. Reile, G. Bernhardt, M. Koch, H. Schönenberger, M. Hollstein and F. Lux, Cancer Chemother. Pharmacol., 30 (1992) 113-122.
48. F. Bernges and E. Holler, Eur. J. Biochem., 208 (1992) 573-579.